This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
1. Aldejohann A.M., Wiese-Posselt M., Gastmeier P., Kurzai O.: Expert recommendations for prevention and management of Candida auris transmission. Mycoses, 65, 590–598 (2022)AldejohannA.M.Wiese-PosseltM.GastmeierP.KurzaiO.:Expert recommendations for prevention and management of Candida auris transmission.Mycoses,65,590-598(2022)Search in Google Scholar
2. Arastehfar A., Carvalho A., Nguyen M.H., Hedayati M.T., Netea M.G., Perlin D.S., Hoenigl M.: COVID-19-Associated candidiasis (CAC): An underestimated complication in the absence of immunological predispositions? J. Fungi, DOI: 10.3390/jof6040211 (2020)ArastehfarA.CarvalhoA.NguyenM.H.HedayatiM.T.NeteaM.G.PerlinD.S.HoeniglM.:COVID-19-Associated candidiasis (CAC): An underestimated complication in the absence of immunological predispositions?J. Fungi, DOI: 10.3390/jof6040211 (2020)Search in Google Scholar
3. Arendrup M.C., Jørgensen K.M., Hare R.K., Chowdhary A. In vitro activity of Ibrexafungerp (SCY-078) against Candida auris Isolates as determined by EUCAST methodology and comparison with activity against C. albicans and C. glabrata and with the activities of six comparator agents. Antimicrob. Agents Chemother. 64, e02136-19 (2020)ArendrupM.C.JørgensenK.M.HareR.K.ChowdharyA.In vitro activity of Ibrexafungerp (SCY-078) against Candida auris Isolates as determined by EUCAST methodology and comparison with activity against C. albicans and C. glabrata and with the activities of six comparator agents.Antimicrob. Agents Chemother.64,e02136-19(2020)Search in Google Scholar
4. Arora P., Singh P., Wang Y., Yadav A., Pawar K., Singh A., Padmavati G., Xu J.P., Chowdhary A.: Environmental isolation of Candida auris from the coastal wetlands of Andaman Islands, India. Mbio. DOI: 10.1128/mBio.03181-20 (2021)AroraP.SinghP.WangY.YadavA.PawarK.SinghA.PadmavatiG.XuJ.P.ChowdharyA.:Environmental isolation of Candida auris from the coastal wetlands of Andaman Islands, India.Mbio. DOI: 10.1128/mBio.03181-20 (2021)Search in Google Scholar
5. Bayona J.V.M., Garcia C.S., Palop N.T., Martin A.V., Padron C.G., Rodriguez J.C., Peman J., Cardona C.G.: Novel chromogenic medium CHROMagar(TM) Candida Plus for detection of Candida auris and other Candida species from surveillance and environmental Samples: A Multicenter Study. J. Fungi, DOI: 10.3390/jof8030281 (2022)BayonaJ.V.M.GarciaC.S.PalopN.T.MartinA.V.PadronC.G.RodriguezJ.C.PemanJ.CardonaC.G.:Novel chromogenic medium CHROMagar(TM) Candida Plus for detection of Candida auris and other Candida species from surveillance and environmental Samples: A Multicenter Study.J. Fungi, DOI: 10.3390/jof8030281 (2022)Search in Google Scholar
6. Ben-Ami R., Berman J., Novikov A., Bash E., Shachor-Meyouhas Y., Zakin S., Maor Y., Tarabia J., Schechner V., Adler A., Finn T.: Multidrug-Resistant Candida haemulonii and C-auris, Tel Aviv, Israel. Emerg. Infect. Dis. 23, 195–203 (2017)Ben-AmiR.BermanJ.NovikovA.BashE.Shachor-MeyouhasY.ZakinS.MaorY.TarabiaJ.SchechnerV.AdlerA.FinnT.:Multidrug-Resistant Candida haemulonii and C-auris, Tel Aviv, Israel.Emerg. Infect. Dis.23,195-203(2017)Search in Google Scholar
7. Bhattacharya S., Holowka T., Orner E.P., Fries B.C.: Gene duplication associated with increased fluconazole tolerance in Candida auris cells of advanced generational age. Sci. Rep. DOI: 10.1038/s41598-019-41513-6 (2019)BhattacharyaS.HolowkaT.OrnerE.P.FriesB.C.:Gene duplication associated with increased fluconazole tolerance in Candida auris cells of advanced generational age.Sci. Rep. DOI: 10.1038/s41598-019-41513-6 (2019)Search in Google Scholar
8. Bing J., Hu T.R., Zheng Q.S., Munoz J.F., Cuomo C.A., Huang G.H.: Experimental evolution identifies adaptive aneuploidy as a mechanism of fluconazole resistance in Candida auris. Antimicrob. Agents Chemother. DOI: 10.1128/AAC.01466-20 (2021)BingJ.HuT.R.ZhengQ.S.MunozJ.F.CuomoC.A.HuangG.H.:Experimental evolution identifies adaptive aneuploidy as a mechanism of fluconazole resistance in Candida auris.Antimicrob. Agents Chemother. DOI: 10.1128/AAC.01466-20 (2021)Search in Google Scholar
9. Borman A.M., Fraser M., Johnson E.M.: CHROMagar (TM) Candida Plus: A novel chromogenic agar that permits the rapid identification of Candida auris. Med. Mycol. 59, 253–258 (2021)BormanA.M.FraserM.JohnsonE.M.:CHROMagar (TM) Candida Plus: A novel chromogenic agar that permits the rapid identification of Candida auris.Med. Mycol.59,253-258(2021)Search in Google Scholar
10. Borman A.M., Szekely A., Johnson E.M.: Comparative pathogenicity of United Kingdom Isolates of the emerging pathogen Candida auris and other key pathogenic Candida species. Msphere, DOI: 10.1128/mSphere.00189-16 (2016)BormanA.M.SzekelyA.JohnsonE.M.:Comparative pathogenicity of United Kingdom Isolates of the emerging pathogen Candida auris and other key pathogenic Candida species.Msphere, DOI: 10.1128/mSphere.00189-16 (2016)Search in Google Scholar
11. Borman A.M., Szekely A., Johnson E.M.: Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins. Med. Mycol. 55, 563–567 (2017)BormanA.M.SzekelyA.JohnsonE.M.:Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins.Med. Mycol.55,563-567(2017)Search in Google Scholar
12. Brown J.L., Delane C., Short B., Butcher M.C., McKloud E., Williams C., Kean R., Ramage G.: Candida auris phenotypic heterogeneity determines pathogenicity in vitro. Msphere, DOI: 10.1128/mSphere (2020)BrownJ.L.DelaneC.ShortB.ButcherM.C.McKloudE.WilliamsC.KeanR.RamageG.:Candida auris phenotypic heterogeneity determines pathogenicity in vitro.Msphere, DOI: 10.1128/mSphere (2020)Search in Google Scholar
13. Bruno M., Kersten S., Bain J.M., Jaeger M., Rosati D., Kruppa M.D., Lowman D.W., Rice P.J., Graves B., Ma Z.C., i wsp.: Transcriptional and functional insights into the host immune response against the emerging fungal pathogen Candida auris. Nat. Microbiol. 5, 1516–1531 (2020)BrunoM.KerstenS.BainJ.M.JaegerM.RosatiD.KruppaM.D.LowmanD.W.RiceP.J.GravesB.MaZ.C.,i wsp.: Transcriptional and functional insights into the host immune response against the emerging fungal pathogen Candida auris.Nat. Microbiol.5,1516-1531(2020)Search in Google Scholar
14. Calvo B., Melo A.S.A., Perozo-Mena A., Hernandez M., Francisco E.C., Hagen F., Meis J.F., Colombo A.L.: First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. J. Infect. 73, 369–374 (2016)CalvoB.MeloA.S.A.Perozo-MenaA.HernandezM.FranciscoE.C.HagenF.MeisJ.F.ColomboA.L.:First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia.J. Infect.73,369-374(2016)Search in Google Scholar
15. Casadevall A., Kontoyiannis D.P., Robert V.: On the emergence of Candida auris: climate change, azoles, swamps, and birds. Mbio, 23, e01397-19 (2019)CasadevallA.KontoyiannisD.P.RobertV.:On the emergence of Candida auris: climate change, azoles, swamps, and birds.Mbio,23,e01397-19(2019)Search in Google Scholar
16. Chakrabarti A., Sood P., Rudramurthy S.M., Chen S., Kaur H., Capoor M., Chhina D., Rao R., Eshwara V.K., Xess I., i wsp.: Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med. 41, 285–295(2015)ChakrabartiA.SoodP.RudramurthyS.M.ChenS.KaurH.CapoorM.ChhinaD.RaoR.EshwaraV.K.XessI.,i wsp.: Incidence, characteristics and outcome of ICU-acquired candidemia in India.Intensive Care Med.41,285-295(2015)Search in Google Scholar
17. Chatterjee S., Alampalli S.V., Nageshan R.K., Chettiar S.T., Joshi S., Tatu U.S.: Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris. BMC Genomics. DOI: 10.1186/s12864-015-1863-z (2015)ChatterjeeS.AlampalliS.V.NageshanR.K.ChettiarS.T.JoshiS.TatuU.S.:Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris.BMC Genomics. DOI: 10.1186/s12864-015-1863-z (2015)Search in Google Scholar
18. Chow N.A., de Groot T., Badali H., Abastabar M., Chiller T.M., Meis J.F.: Potential fifth clade of Candida auris, Iran, 2018. Emerg. Infect. Dis. 2, 1780–1781 (2019)ChowN.A.de GrootT.BadaliH.AbastabarM.ChillerT.M.MeisJ.F.:Potential fifth clade of Candida auris, Iran, 2018.Emerg. Infect. Dis.2,1780-1781(2019)Search in Google Scholar
19. Chow N.A., Munoz J.F., Gade L., Berkow E.L., Li X., Welsh R.M., Forsberg K., Lockhart S.R., Adam R., Alanio A., i wsp.: Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses. Mbio. DOI: 10.1128/mBio.03364-19 (2020)ChowN.A.MunozJ.F.GadeL.BerkowE.L.LiX.WelshR.M.ForsbergK.LockhartS.R.AdamR.AlanioA.,i wsp.: Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses.Mbio. DOI: 10.1128/mBio.03364-19 (2020)Search in Google Scholar
20. Chowdhary A., Kumar V.A., Sharma C., Prakash A., Agarwal K., Babu R. Dinesh K.R., Karim S., Singh S.K., Hagen F., Meis J.F.: Multidrug-resistant endemic clonal strain of Candida auris in India. Eur. J. Clin. Microbiol. Infect. Dis. 33, 919–926 (2014)ChowdharyA.KumarV.A.SharmaC.PrakashA.AgarwalK.BabuR.DineshK.R.KarimS.SinghS.K.HagenF.MeisJ.F.:Multidrug-resistant endemic clonal strain of Candida auris in India.Eur. J. Clin. Microbiol. Infect. Dis.33,919-926(2014)Search in Google Scholar
21. Chowdhary A., Prakash A., Sharma C., Kordalewska M., Kumar A., Sarma S., Tarai B., Singh A., Upadhyaya G., Upadhyay S., i wsp.: A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J. Antimicrob. Chemother. 73, 891–899 (2018)ChowdharyA.PrakashA.SharmaC.KordalewskaM.KumarA.SarmaS.TaraiB.SinghA.UpadhyayaG.UpadhyayS.,i wsp.: A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.J. Antimicrob. Chemother.73,891-899(2018)Search in Google Scholar
22. Chowdhary A., Sharma C., Duggal S., Agarwal K., Prakash A., Singh P.K., Jain S., Kathuria S., Randhawa H.S., Hagen F., Meis J.F.: New clonal strain of Candida auris, Delhi, India. Emerg. Infect. Dis. 19, 1670–1673 (2013)ChowdharyA.SharmaC.DuggalS.AgarwalK.PrakashA.SinghP.K.JainS.KathuriaS.RandhawaH.S.HagenF.MeisJ.F.:New clonal strain of Candida auris, Delhi, India.Emerg. Infect. Dis.19,1670-1673(2013)Search in Google Scholar
23. Chowdhary A., Sharma C., Meis J.F.: Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. Plos Pathogens DOI: 10.1371/journal.ppat.1006290 (2017)ChowdharyA.SharmaC.MeisJ.F.:Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally.Plos PathogensDOI: 10.1371/journal.ppat.1006290 (2017)Search in Google Scholar
24. Chowdhary A., Tarai B., Singh A., Sharma A.: Multidrug-Resistant Candida auris infections in critically ill coronavirus disease patients, India, April-July 2020. Emer. Infect. Dis. 26, 2694–2696 (2020)ChowdharyA.TaraiB.SinghA.SharmaA.:Multidrug-Resistant Candida auris infections in critically ill coronavirus disease patients, India, April-July 2020.Emer. Infect. Dis.26,2694-2696(2020)Search in Google Scholar
25. Chybowska A.D., Childers D.S., Farrer R.A.: Nine things genomics can tell us about Candida auris. Front.Gen. DOI: 10.3389/fgene.2020.00351 (2020)ChybowskaA.D.ChildersD.S.FarrerR.A.:Nine things genomics can tell us about Candida auris.Front.Gen. DOI: 10.3389/fgene.2020.00351 (2020)Search in Google Scholar
26. Cleare L.G., Li K.L., Abuzeid W.M., Nacharaju P., Friedman J.M., Nosanchuk J.D. NO Candida auris: Nitric oxide in nanotherapeutics to combat emerging fungal pathogen Candida auris. J Fungi (Basel). DOI: 10.3390/jof6020085 (2020).CleareL.G.LiK.L.AbuzeidW.M.NacharajuP.FriedmanJ.M.NosanchukJ.D.NO Candida auris: Nitric oxide in nanotherapeutics to combat emerging fungal pathogen Candida auris.J Fungi (Basel). DOI: 10.3390/jof6020085 (2020).Search in Google Scholar
27. Cortegiani A., Misseri G., Fasciana T., Giammanco A., Giarratano A., Chowdhary A.: Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris. J. Intensive Care. DOI: 10.1186/s40560-018-0342-4 (2018)CortegianiA.MisseriG.FascianaT.GiammancoA.GiarratanoA.ChowdharyA.:Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris.J. Intensive Care. DOI: 10.1186/s40560-018-0342-4 (2018)Search in Google Scholar
28. Cortegiani A., Misseri G., Giarratano A., Bassetti M., Eyre D.: The global challenge of Candida auris in the intensive care unit. Crit. Care, 23, 3 (2019)CortegianiA.MisseriG.GiarratanoA.BassettiM.EyreD.:The global challenge of Candida auris in the intensive care unit.Crit. Care,23,3(2019)Search in Google Scholar
29. Dal Mas C., Rossato L., Shimizu T., Oliveira E.B., da Silva Junior P.I., Meis J.F., Colombo A.L., Hayashi M.A.F.: Effects of the natural peptide crotamine from a South American rattlesnake on Candida auris, an emergent multidrug antifungal resistant human pathogen. Biomolecules. DOI: 10.3390/biom9060205 (2019)Dal MasC.RossatoL.ShimizuT.OliveiraE.B.da Silva JuniorP.I.MeisJ.F.ColomboA.L.HayashiM.A.F.:Effects of the natural peptide crotamine from a South American rattlesnake on Candida auris, an emergent multidrug antifungal resistant human pathogen.Biomolecules. DOI: 10.3390/biom9060205 (2019)Search in Google Scholar
30. Das S., Singh S., Tawde Y., Chakrabarti A., Rudramurthy S.M., Kaur H., Shankarnarayan S.A., Ghosh A.: A selective medium for isolation and detection of candida auris, an emerging pathogen. J. Clin. Microbiol. DOI: 10.1128/JCM.00326-20. (2021)DasS.SinghS.TawdeY.ChakrabartiA.RudramurthyS.M.KaurH.ShankarnarayanS.A.GhoshA.:A selective medium for isolation and detection of candida auris, an emerging pathogen.J. Clin. Microbiol. DOI: 10.1128/JCM.00326-20. (2021)Search in Google Scholar
31. de Jong A.W., Dieleman C., Carbia M., Tap R.M., Hagen F.: Performance of two novel chromogenic media for the identification of multidrug-resistant Candida auris compared with other commercially available formulations. J. Clin. Microbiol. DOI: 10.1128/JCM.03220-20 (2021).de JongA.W.DielemanC.CarbiaM.TapR.M.HagenF.:Performance of two novel chromogenic media for the identification of multidrug-resistant Candida auris compared with other commercially available formulations.J. Clin. Microbiol. DOI: 10.1128/JCM.03220-20 (2021).Search in Google Scholar
32. de Jong A.W., Francisco E.C., de Almeida J.N., Brandao I.B., Pereira F.M., Dias P.H.P., Costa M.D.M., Jordao R.T.D., Vu D., Colombo A.L., Hagen F.: Nanopore genome sequencing and variant analysis of the susceptible Candida auris strain L1537/2020, Salvador, Brazil. Mycopathologia, 186, 883–887 (2021)de JongA.W.FranciscoE.C.de AlmeidaJ.N.BrandaoI.B.PereiraF.M.DiasP.H.P.CostaM.D.M.JordaoR.T.D.VuD.ColomboA.L.HagenF.:Nanopore genome sequencing and variant analysis of the susceptible Candida auris strain L1537/2020, Salvador, Brazil.Mycopathologia,186,883-887(2021)Search in Google Scholar
33. Desoubeaux G., Coste A.T., Imbert C., Hennequin C.: Overview about Candida auris: what’s up 12 years after its first description? J. Mycol. Med. DOI: 10.1016/j.mycmed.2022.101248 (2022)DesoubeauxG.CosteA.T.ImbertC.HennequinC.:Overview about Candida auris: what’s up 12 years after its first description?J. Mycol. Med. DOI: 10.1016/j.mycmed.2022.101248 (2022)Search in Google Scholar
34. Du H., Bing J., Hu T.R., Ennis C.L., Nobile C.J., Huang G.H.: Candida auris: Epidemiology, biology, antifungal resistance, and virulence. Plos Pathogens, DOI: 10.1371/journal.ppat.1008921 (2020)DuH.BingJ.HuT.R.EnnisC.L.NobileC.J.HuangG.H.:Candida auris: Epidemiology, biology, antifungal resistance, and virulence.Plos Pathogens, DOI: 10.1371/journal.ppat.1008921 (2020)Search in Google Scholar
35. Emara M., Ahmad S., Khan Z., Joseph L., Al-Obaid I., Purohit P., Bafna R.: Candida auris candidemia in Kuwait, 2014. Emer. Infect. Dis. 21, 1091–1092 (2015)EmaraM.AhmadS.KhanZ.JosephL.Al-ObaidI.PurohitP.BafnaR.:Candida auris candidemia in Kuwait, 2014.Emer. Infect. Dis.21,1091-1092(2015)Search in Google Scholar
36. Escandon P., Chow N.A., Caceres D.H., Gade L., Berkow E.L., Armstrong P., Rivera S., Misas E., Duarte C., Moulton-Meissner H., i wsp. : Molecular epidemiology of Candida auris in Colombia reveals a highly related, countrywide colonization with regional patterns in amphotericin B resistance. Clin. Infect. Dis. 68, 15–21 (2019)EscandonP.ChowN.A.CaceresD.H.GadeL.BerkowE.L.ArmstrongP.RiveraS.MisasE.DuarteC.Moulton-MeissnerH.,i wsp. : Molecular epidemiology of Candida auris in Colombia reveals a highly related, countrywide colonization with regional patterns in amphotericin B resistance.Clin. Infect. Dis.68,15-21(2019)Search in Google Scholar
37. Fakhim H., Vaezi A., Dannaoui E., Chowdhary A., Nasiry D., Faeli L., Meis J.F., Badali H.: Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model. Mycoses, 61, 377–382 (2018)FakhimH.VaeziA.DannaouiE.ChowdharyA.NasiryD.FaeliL.MeisJ.F.BadaliH.:Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model.Mycoses,61,377-382(2018)Search in Google Scholar
38. Fan S.R., Yue H.Z., Zheng Q.S., Bing J., Tian S.F., Chen J.J., Ennis C.L., Nobile C.J., Huang G.H., Du H.: Filamentous growth is a general feature of Candida auris clinical isolates. Med.Mycol. 59, 734–740 (2021)FanS.R.YueH.Z.ZhengQ.S.BingJ.TianS.F.ChenJ.J.EnnisC.L.NobileC.J.HuangG.H.DuH.:Filamentous growth is a general feature of Candida auris clinical isolates.Med.Mycol.59,734-740(2021)Search in Google Scholar
39. Fan S.R., Zhan P., Bing J., Jiang N., Huang Y.N., Chen D.K., Hu T.R., Du H., Huang G.H.: A biological and genomic comparison of a drug-resistant and a drug-susceptible strain of Candida auris isolated from Beijing, China. Virulence, 12, 1388–1399 (2021)FanS.R.ZhanP.BingJ.JiangN.HuangY.N.ChenD.K.HuT.R.DuH.HuangG.H.:A biological and genomic comparison of a drug-resistant and a drug-susceptible strain of Candida auris isolated from Beijing, China.Virulence,12,1388-1399(2021)Search in Google Scholar
40. Fasciana T., Cortegiani A., Ippolito M., Giarratano A., Di Quattro O., Lipari D., Graceffa D., Giammanco A.: Candida auris: An Overview of how to screen, detect, test and control this emerging pathogen. Antibiotics-Basel, DOI: 10.3390/antibiotics9110778 (2020)FascianaT.CortegianiA.IppolitoM.GiarratanoA.Di QuattroO.LipariD.GraceffaD.GiammancoA.:Candida auris: An Overview of how to screen, detect, test and control this emerging pathogen.Antibiotics-Basel, DOI: 10.3390/antibiotics9110778 (2020)Search in Google Scholar
41. Forgacs L., Borman A.M., Prepost E., Toth Z., Kardos G., Kovacs R., Szekely A., Nagy F., Majoros L., Kovacs I.: Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model. Emerg. Microbes Infect. 9, 1160–1169 (2020)ForgacsL.BormanA.M.PrepostE.TothZ.KardosG.KovacsR.SzekelyA.NagyF.MajorosL.KovacsI.:Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model.Emerg. Microbes Infect.9,1160-1169(2020)Search in Google Scholar
42. Freitas B.L., Leach L., Chaturvedi V., Chaturvedi S.: Reverse Transcription-Quantitative Real-Time PCR (RT-qPCR) Assay for the rapid enumeration of live Candida auris cells from the health care environment. J. Clin. Microbiol. DOI: 10.1128/JCM.00779-21 (2022)FreitasB.L.LeachL.ChaturvediV.ChaturvediS.:Reverse Transcription-Quantitative Real-Time PCR (RT-qPCR) Assay for the rapid enumeration of live Candida auris cells from the health care environment.J. Clin. Microbiol. DOI: 10.1128/JCM.00779-21 (2022)Search in Google Scholar
43. Fuchs F., Hof H., Hofmann S., Kurzai O., Meis J.F., Hamprecht A. Antifungal activity of nitroxoline against Candida auris isolates. Clin. Microbiol. Infect. 27, 1697.e7-1697.e10 (2021)FuchsF.HofH.HofmannS.KurzaiO.MeisJ.F.HamprechtA.Antifungal activity of nitroxoline against Candida auris isolates.Clin. Microbiol. Infect.27,1697.e7-1697.e10(2021)Search in Google Scholar
44. Gaitan A.C.R., Moret A., Hontangas J..L., Molina J.M., Lopez A.I.A., Cabezas A.H., Maseres J.M., Arcas R.C., Ruiz M.D.G., Chiveli M.A. i wsp.: Nosocomial fungemia by Candida auris: First four reported cases in continental Europe. Rev. Iberoam. Micol. 34, 23–27 (2017)GaitanA.C.R.MoretA.HontangasJ..L., MolinaJ.M.LopezA.I.A.CabezasA.H.MaseresJ.M.ArcasR.C.RuizM.D.G.ChiveliM.A.i wsp.: Nosocomial fungemia by Candida auris: First four reported cases in continental Europe.Rev. Iberoam. Micol.34,23-27(2017)Search in Google Scholar
45. Garcia-Bustos V., Cabanero-Navalon M.D., Ruiz-Sauri A., Ruiz-Gaitan A.C., Salavert M., Tormo M.A., Peman J.: What Do We know about Candida auris? State of the art, knowledge gaps, and future directions. Microorganisms, DOI: 10.3390/microorganisms9102177 (2021)Garcia-BustosV.Cabanero-NavalonM.D.Ruiz-SauriA.Ruiz-GaitanA.C.SalavertM.TormoM.A.PemanJ.:What Do We know about Candida auris? State of the art, knowledge gaps, and future directions.Microorganisms, DOI: 10.3390/microorganisms9102177 (2021)Search in Google Scholar
46. Garcia-Bustos V., Peman J., Ruiz-Gaitan A., Cabanero-Navalon M.D., Cabanilles-Boronat A., Fernandez-Calduch M., Marcilla-Barreda L., Sigona-Giangreco I.A., Salavert M., Tormo-Mas M.A., Ruiz-Sauri A.: Host-pathogen interactions upon Candida auris infection: fungal behaviour and immune response in Galleria mellonella. Emerg. Microbes Infect. 11, 136–146 (2022)Garcia-BustosV.PemanJ.Ruiz-GaitanA.Cabanero-NavalonM.D.Cabanilles-BoronatA.Fernandez-CalduchM.Marcilla-BarredaL.Sigona-GiangrecoI.A.SalavertM.Tormo-MasM.A.Ruiz-SauriA.:Host-pathogen interactions upon Candida auris infection: fungal behaviour and immune response in Galleria mellonella.Emerg. Microbes Infect.11,136-146(2022)Search in Google Scholar
47. Garcia-Bustos V., Ruiz-Sauri A., Ruiz-Gaitan A., Sigona-Giangreco I.A., Cabanero-Navalon M.D., Sabalza-Baztan O., Salavert-Lleti M., Tormo M.A., Peman J.: Characterization of the differential pathogenicity of Candida auris in a Galleria mellonella infection model. Microbiol. Spectr. DOI: 10.1128/Spectrum.00013-21 (2021)Garcia-BustosV.Ruiz-SauriA.Ruiz-GaitanA.Sigona-GiangrecoI.A.Cabanero-NavalonM.D.Sabalza-BaztanO.Salavert-LletiM.TormoM.A.PemanJ.:Characterization of the differential pathogenicity of Candida auris in a Galleria mellonella infection model.Microbiol. Spectr. DOI: 10.1128/Spectrum.00013-21 (2021)Search in Google Scholar
48. Hager C.L., Larkin E.L., Long L., Zohra Abidi F., Shaw K.J., Ghannoum M.A. In vitro and in Vivo evaluation of the antifungal activity of APX001A/APX001 against Candida auris. Antimicrob. Agents Chem-other. DOI: 10.1128/AAC.02319-17 (2018)HagerC.L.LarkinE.L.LongL.Zohra AbidiF.ShawK.J.GhannoumM.A.In vitro and in Vivo evaluation of the antifungal activity of APX001A/APX001 against Candida auris.Antimicrob. Agents Chem-other. DOI: 10.1128/AAC.02319-17 (2018)Search in Google Scholar
49. Hamprecht A., Barber A.E., Mellinghoff S.C., Thelen P., Walther G., Yu Y.Y., Neurgaonkar P., Dandekar T., Cornely O.A., Martin R., i wsp.: Candida auris in Germany and previous exposure to foreign healthcare. Emerg. Infect. Dis. 25, 1763–1765 (2019)HamprechtA.BarberA.E.MellinghoffS.C.ThelenP.WaltherG.YuY.Y.NeurgaonkarP.DandekarT.CornelyO.A.MartinR.,i wsp.: Candida auris in Germany and previous exposure to foreign healthcare.Emerg. Infect. Dis.25,1763-1765(2019)Search in Google Scholar
50. Han Y.Y., Liu D.D., Li L.H.: PD-1/PD-L1 pathway: current researches in cancer. Am. J. Cancer Res. 10, 727–742 (2020)HanY.Y.LiuD.D.LiL.H.:PD-1/PD-L1 pathway: current researches in cancer.Am. J. Cancer Res.10,727-742(2020)Search in Google Scholar
51. Hanson B.M., Dinh A.Q., Tran T.T., Arenas S., Pronty D., Gershengorn H.B., Ferreira T., Arias C.A., Shukla B.S.: Candida auris invasive infections during a COVID-19 case surge. Antimicrob. Agents Chemother. DOI: 10.1128/AAC.01146-21 (2021)HansonB.M.DinhA.Q.TranT.T.ArenasS.ProntyD.GershengornH.B.FerreiraT.AriasC.A.ShuklaB.S.:Candida auris invasive infections during a COVID-19 case surge.Antimicrob. Agents Chemother. DOI: 10.1128/AAC.01146-21 (2021)Search in Google Scholar
52. Hoenigl M., Seidel D., Sprute R., Cunha C., Oliverio M., Goldman G.H., Ibrahim A.S., Carvalho A.: COVID-19-associated fungal infections. Nat. Microbiol. 7, 1127–1140 (2022)HoeniglM.SeidelD.SpruteR.CunhaC.OliverioM.GoldmanG.H.IbrahimA.S.CarvalhoA.:COVID-19-associated fungal infections.Nat. Microbiol.7,1127-1140(2022)Search in Google Scholar
53. Horton M.V., Johnson C.J., Zarnowski R., Andes B.D., Schoen T.J., Kernien J.F., Lowman D., Kruppa M.D., Ma Z.C., Williams D.L. i wsp.: Candida auris cell wall mannosylation contributes to neutrophil evasion through pathways divergent from Candida albicans and Candida glabrata. Msphere, DOI: 10.1128/mSphere.00406-21 (2021)HortonM.V.JohnsonC.J.ZarnowskiR.AndesB.D.SchoenT.J.KernienJ.F.LowmanD.KruppaM.D.MaZ.C.WilliamsD.L.i wsp.: Candida auris cell wall mannosylation contributes to neutrophil evasion through pathways divergent from Candida albicans and Candida glabrata.Msphere, DOI: 10.1128/mSphere.00406-21 (2021)Search in Google Scholar
54. Ibrahim A., Peyclit L., Abdallah R., Khelaifia S., Chamieh A., Rolain J.M., Bittar F.: SCA Medium: A new culture medium for the isolation of all Candida auris clades. J. Fungi, DOI: 10.3390/jof7060433 (2021)IbrahimA.PeyclitL.AbdallahR.KhelaifiaS.ChamiehA.RolainJ.M.BittarF.:SCA Medium: A new culture medium for the isolation of all Candida auris clades.J. Fungi, DOI: 10.3390/jof7060433 (2021)Search in Google Scholar
55. Izadi A. Gharehbolagh S.A., Sadeghi F., Talebi M., Darmiani K., Zarrinnia A., Zarei F., Peymaeei F., Khojasteh S., Borman A.M., Mahmoudi S.: Drug repurposing against Candida auris: a systematic review. Mycoses, 65, 784–793 (2022)IzadiA.GharehbolaghS.A.SadeghiF.TalebiM.DarmianiK.ZarrinniaA.ZareiF.PeymaeeiF.KhojastehS.BormanA.M.MahmoudiS.:Drug repurposing against Candida auris: a systematic review.Mycoses,65,784-793(2022)Search in Google Scholar
56. Johnson C.J., Davis J.M., Huttenlocher A., Kernien J.F., Nett J.E.: Emerging fungal pathogen Candida auris evades neutrophil attack. Mbio, DOI: 10.1128/mBio.01403-18 (2018)JohnsonC.J.DavisJ.M.HuttenlocherA.KernienJ.F.NettJ.E.:Emerging fungal pathogen Candida auris evades neutrophil attack.Mbio, DOI: 10.1128/mBio.01403-18 (2018)Search in Google Scholar
57. Kean R, McKloud E, Townsend E,M, Sherry L, Delaney C., Jones B,L, Williams C, Ramage G,: The comparative efficacy of antiseptics against Candida auris biofilms. Int. J. Antimicrob. Agents, 52, 673–677 (2018)KeanRMcKloudETownsendE,MSherryLDelaneyC.JonesB,LWilliamsCRamageG,:The comparative efficacy of antiseptics against Candida auris biofilms.Int. J. Antimicrob. Agents,52,673-677(2018)Search in Google Scholar
58. Kean R., Brown J., Gulmez D., Ware A., Ramage G.: Candida auris: a decade of understanding of an enigmatic pathogenic yeast. J. Fungi, DOI: 10.3390/jof6010030 (2020)KeanR.BrownJ.GulmezD.WareA.RamageG.:Candida auris: a decade of understanding of an enigmatic pathogenic yeast.J. Fungi, DOI: 10.3390/jof6010030 (2020)Search in Google Scholar
59. Kean R., Delaney C., Sherry L., Borman A., Johnson E.M., Richardson M.D., Rautemaa-Richardson R., Williams C., Ramage G.: Transcriptome assembly and profiling of Candida auris reveals novel insights into biofilm-mediated resistance. Msphere, DOI: 10.1128/mSphere.00334-18 (2018)KeanR.DelaneyC.SherryL.BormanA.JohnsonE.M.RichardsonM.D.Rautemaa-RichardsonR.WilliamsC.RamageG.:Transcriptome assembly and profiling of Candida auris reveals novel insights into biofilm-mediated resistance.Msphere, DOI: 10.1128/mSphere.00334-18 (2018)Search in Google Scholar
60. Kim M.N., Shin J.H., Sung H., Lee K., Kim E.C., Ryoo N., Lee J.S., Jung S.I., Park K.H., Kee S.J., i wsp.: Candida haemulonii and closely related species at 5 university hospitals in Korea: Identification, antifungal susceptibility, and clinical features. Clin. Infect. Dis. 48, e57–e61 (2009)KimM.N.ShinJ.H.SungH.LeeK.KimE.C.RyooN.LeeJ.S.JungS.I.ParkK.H.KeeS.J.,i wsp.: Candida haemulonii and closely related species at 5 university hospitals in Korea: Identification, antifungal susceptibility, and clinical features.Clin. Infect. Dis.48,e57-e61(2009)Search in Google Scholar
61. Kordalewska M., Lee A., Park S., Berrio I., Chowdhary A., Zhao Y.A., Perlin D.S.: Understanding echinocandin resistance in the emerging pathogen Candida auris. Antimicrob. Agents Chemother. DOI: 10.1128/AAC.00238-18 (2018)KordalewskaM.LeeA.ParkS.BerrioI.ChowdharyA.ZhaoY.A.PerlinD.S.:Understanding echinocandin resistance in the emerging pathogen Candida auris.Antimicrob. Agents Chemother. DOI: 10.1128/AAC.00238-18 (2018)Search in Google Scholar
62. Kordalewska M., Perlin D..S.: Identification of drug resistant Candida auris. Front. Microbiol. DOI: 10.3389/fmicb.2019.01918 (2019)KordalewskaM.PerlinD..S.:Identification of drug resistant Candida auris.Front. Microbiol. DOI: 10.3389/fmicb.2019.01918 (2019)Search in Google Scholar
63. Kumar A., Sachu A., Mohan K., Vinod V., Dinesh K., Karim S.: Simple low cost differentiation of Candida auris from Candida haemulonii complex using CHROMagar Candida medium supplemented with Pal’s medium. Rev. Iberoam. Micol. 34, 109–111 (2017)KumarA.SachuA.MohanK.VinodV.DineshK.KarimS.:Simple low cost differentiation of Candida auris from Candida haemulonii complex using CHROMagar Candida medium supplemented with Pal’s medium.Rev. Iberoam. Micol.34,109-111(2017)Search in Google Scholar
64. Kumar D., Banerjee T., Pratap C.B., Tilak R.: Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis. J. Infect. Dev. Ctries, 9, 435–437 (2015)KumarD.BanerjeeT.PratapC.B.TilakR.:Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis.J. Infect. Dev. Ctries,9,435-437(2015)Search in Google Scholar
65. Leach L., Zhu Y., Chaturvedi S.: Development and validation of a Real-Time PCR assay for rapid detection of Candida auris from surveillance samples. J. Clin. Microbiol. DOI: 10.1128/JCM.01223-17 (2018)LeachL.ZhuY.ChaturvediS.:Development and validation of a Real-Time PCR assay for rapid detection of Candida auris from surveillance samples.J. Clin. Microbiol. DOI: 10.1128/JCM.01223-17 (2018)Search in Google Scholar
66. Lee W.G., Shin J.H., Uh Y., Kang M.G., Kim S.H., Park K.H., Jang H.C.: First three reported cases of nosocomial fungemia caused by Candida auris. J. Clin. Microbiol. 49, 3139–3142 (2011)LeeW.G.ShinJ.H.UhY.KangM.G.KimS.H.ParkK.H.JangH.C.:First three reported cases of nosocomial fungemia caused by Candida auris.J. Clin. Microbiol.49,3139-3142(2011)Search in Google Scholar
67. Lepak A.J., Zhao M., Andes D.R. Pharmacodynamic evaluation of rezafungin (cd101) against Candida auris in the neutropenic mouse invasive candidiasis model. Antimicrob. Agents Chemother. DOI: 10.1128/AAC.01572-18 (2018)LepakA.J.ZhaoM.AndesD.R.Pharmacodynamic evaluation of rezafungin (cd101) against Candida auris in the neutropenic mouse invasive candidiasis model.Antimicrob. Agents Chemother. DOI: 10.1128/AAC.01572-18 (2018)Search in Google Scholar
68. Lockhart S.R., Etienne K.A., Vallabhaneni S., Farooqi J., Chowdhary A., Govender N.P., Colombo A.L., Calvo B., Cuomo C.A., Desjardins C.A. i wsp. : Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin. Infect. Dis. 64, 134–140 (2017)LockhartS.R.EtienneK.A.VallabhaneniS.FarooqiJ.ChowdharyA.GovenderN.P.ColomboA.L.CalvoB.CuomoC.A.DesjardinsC.A.i wsp. : Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses.Clin. Infect. Dis.64,134-140(2017)Search in Google Scholar
69. Lockhart S.R., Lyman M.M., Sexton D.J.: Tools for detecting a “Superbug”: Updates on Candida auris testing. J. Clin. Microbiol. DOI: 10.1128/jcm.00808-21 (2022)LockhartS.R.LymanM.M.SextonD.J.:Tools for detecting a “Superbug”: Updates on Candida auris testing.J. Clin. Microbiol. DOI: 10.1128/jcm.00808-21 (2022)Search in Google Scholar
70. Magnasco L., Mikulska M., Giacobbe D.R., Taramasso L., Vena A., Dentone C., Dettori S., Tutino S., Labate L., di Pilato V., i wsp.: spread of Carbapenem-Resistant Gram-negatives and Candida auris during the COVID-19 pandemic in critically ill patients: one step back in antimicrobial stewardship? Microorganisms. DOI: 10.3390/microorganisms9010095 (2021)MagnascoL.MikulskaM.GiacobbeD.R.TaramassoL.VenaA.DentoneC.DettoriS.TutinoS.LabateL.di PilatoV.,i wsp.: spread of Carbapenem-Resistant Gram-negatives and Candida auris during the COVID-19 pandemic in critically ill patients: one step back in antimicrobial stewardship?Microorganisms. DOI: 10.3390/microorganisms9010095 (2021)Search in Google Scholar
71. Magobo R.E., Corcoran C., Seetharam S., Govender N.P.: Candida auris-associated candidemia, South Africa. Emerg. Infect. Dis. 20, 1250–1251 (2014)MagoboR.E.CorcoranC.SeetharamS.GovenderN.P.:Candida auris-associated candidemia, South Africa.Emerg. Infect. Dis.20,1250-1251(2014)Search in Google Scholar
72. Munoz J.F., Gade L., Chow N.A., Loparev V.N., Juieng P., Berkow E.L., Farrer R.A., Litvintseva A.P., Cuomo C.A.: Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species. Nat. Commun. DOI:10.1038/s41467-018-07779-6 (2018)MunozJ.F.GadeL.ChowN.A.LoparevV.N.JuiengP.BerkowE.L.FarrerR.A.LitvintsevaA.P.CuomoC.A.:Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species.Nat. Commun. DOI:10.1038/s41467-018-07779-6 (2018)Search in Google Scholar
73. Nett J.E.: Candida auris: An emerging pathogen “incognito”? Plos Pathogens. DOI: 10.1371/journal.ppat.1007638 (2019)NettJ.E.:Candida auris: An emerging pathogen “incognito”?Plos Pathogens. DOI: 10.1371/journal.ppat.1007638 (2019)Search in Google Scholar
74. Pfaller M.A., Diekema D.J., Turnidge J.D., Castanheira M., Jones R.N.: Twenty years of the SENTRY antifungal surveillance program: results for Candida Species from 1997–2016. Open Forum Infec. Dis. 6, S79–S94 (2019)PfallerM.A.DiekemaD.J.TurnidgeJ.D.CastanheiraM.JonesR.N.:Twenty years of the SENTRY antifungal surveillance program: results for Candida Species from 1997–2016.Open Forum Infec. Dis.6,S79–S94(2019)Search in Google Scholar
75. Prestel C., Anderson E., Forsberg K., Lyman M., de Perio M.A., Kuhar D., Edwards K., Rivera M., Shugart A., Walters M., Dotson N.Q.: Candida auris outbreak in a COVID-19 specialty care unit – Florida, July–August 2020. MMWR Morb Mortal Wkly Rep. 70, 56–57 (2021)PrestelC.AndersonE.ForsbergK.LymanM.de PerioM.A.KuharD.EdwardsK.RiveraM.ShugartA.WaltersM.DotsonN.Q.:Candida auris outbreak in a COVID-19 specialty care unit – Florida, July–August 2020.MMWR Morb Mortal Wkly Rep.70,56-57(2021)Search in Google Scholar
76. Proctor D.M., Dangana T., Sexton D.J., Fukuda C., Yelin R.D., Stanley M., Bell P.B., Baskaran S., Deming C., Chen Q. i wsp.: Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility. Nat. Med. 27, 1401–1409 (2021)ProctorD.M.DanganaT.SextonD.J.FukudaC.YelinR.D.StanleyM.BellP.B.BaskaranS.DemingC.ChenQ.i wsp.: Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility.Nat. Med.27,1401-1409(2021)Search in Google Scholar
77. Rajni E., Singh A., Tarai B., Jain K., Shankar R., Pawar K., Mamoria V., Chowdhary A.: A High frequency of Candida auris blood stream infections in coronavirus disease 2019 patients admitted to intensive care units, Northwestern India: a case control study. Open Forum Infect. Dis. DOI: 10.1093/ofid/ofab452 (2021)RajniE.SinghA.TaraiB.JainK.ShankarR.PawarK.MamoriaV.ChowdharyA.:A High frequency of Candida auris blood stream infections in coronavirus disease 2019 patients admitted to intensive care units, Northwestern India: a case control study.Open Forum Infect. Dis. DOI: 10.1093/ofid/ofab452 (2021)Search in Google Scholar
78. Rodriguez J.Y., Le Pape P., Lopez O., Esquea K., Labiosa A.L., Alvarez-Moreno C.: Candida auris: A Latent threat to critically ill patients with coronavirus disease 2019. Clin. Infect. Dis. 73, e2836–e2837 (2021)RodriguezJ.Y.Le PapeP.LopezO.EsqueaK.LabiosaA.L.Alvarez-MorenoC.:Candida auris: A Latent threat to critically ill patients with coronavirus disease 2019.Clin. Infect. Dis.73,e2836-e2837(2021)Search in Google Scholar
79. Rudramurthy S.M., Colley T., Abdolrasouli A., Ashman J., Dhaliwal M., Kaur H., Armstrong-James D., Strong P., Rapeport G., Schelenz S., Ito K., Chakrabarti A. In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris. J. Anti-microb. Chemother. 74, 2943–2949 (2019)RudramurthyS.M.ColleyT.AbdolrasouliA.AshmanJ.DhaliwalM.KaurH.Armstrong-JamesD.StrongP.RapeportG.SchelenzS.ItoK.ChakrabartiA.In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris.J. Anti-microb. Chemother.74,2943-2949(2019)Search in Google Scholar
80. Rybak J.M., Barker K.S., Munoz J.F., Parker J.E., Ahmad S., Mokaddas E., Abdullah A., Elhagracy R.S., Kelly S.L., Cuomo C.A., Rogers P.D.: In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris. Clin. Microbiol. Infect. 28, 838–843 (2022)RybakJ.M.BarkerK.S.MunozJ.F.ParkerJ.E.AhmadS.MokaddasE.AbdullahA.ElhagracyR.S.KellyS.L.CuomoC.A.RogersP.D.:In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris. Clin. Microbiol.Infect.28,838-843(2022)Search in Google Scholar
81. Rybak J.M., Doorley L.A., Nishimoto A.T., Barker K.S., Palmer G.E., Rogers P.D.: Abrogation of triazole resistance upon deletion of CDR1 in a clinical isolate of Candida auris. Antimicrob. Agents Chemother. DOI: 10.1128/AAC.00057-19 (2019)RybakJ.M.DoorleyL.A.NishimotoA.T.BarkerK.S.PalmerG.E.RogersP.D.:Abrogation of triazole resistance upon deletion of CDR1 in a clinical isolate of Candida auris.Antimicrob. Agents Chemother. DOI: 10.1128/AAC.00057-19 (2019)Search in Google Scholar
82. Rybak J.M., Sharma C., Doorley L.A., Barker K.S., Palmer G.E., Rogers P.D.: Delineation of the direct contribution of Candida auris ERG11 mutations to clinical triazole resistance. Microbiol Spectr. DOI: 10.1128/Spectrum.01585-21 (2021)RybakJ.M.SharmaC.DoorleyL.A.BarkerK.S.PalmerG.E.RogersP.D.:Delineation of the direct contribution of Candida auris ERG11 mutations to clinical triazole resistance.Microbiol Spectr. DOI: 10.1128/Spectrum.01585-21 (2021)Search in Google Scholar
83. Sabino R., Verissimo C., Pereira A.A., Antunes F.: Candida auris, an agent of hospital-associated outbreaks: which challenging issues do we need to have in mind? Microorganisms. doi: 10.3390/microorganisms8020181 (2020)SabinoR.VerissimoC.PereiraA.A.AntunesF.:Candida auris, an agent of hospital-associated outbreaks: which challenging issues do we need to have in mind?Microorganisms. doi: 10.3390/microorganisms8020181 (2020)Search in Google Scholar
84. Satoh K., Makimura K., Hasumi Y., Nishiyama Y., Uchida K., Yamaguchi H.: Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol.Immunol. 53, 41–44 (2009)SatohK.MakimuraK.HasumiY.NishiyamaY.UchidaK.YamaguchiH.:Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital.Microbiol.Immunol.53,41-44(2009)Search in Google Scholar
85. Sattler J., Noster J., Brunke A., Plum G., Wiegel P., Kurzai O., Meis J.F., Hamprecht A.: Comparison of two commercially available qPCR kits for the detection of Candida auris. J. Fungi. doi: 10.3390/jof7020154 (2021)SattlerJ.NosterJ.BrunkeA.PlumG.WiegelP.KurzaiO.MeisJ.F.HamprechtA.:Comparison of two commercially available qPCR kits for the detection of Candida auris.J. Fungi. doi: 10.3390/jof7020154 (2021)Search in Google Scholar
86. Schelenz S., Hagen F., Rhodes J.L., Abdolrasouli A., Chowdhary A., Hall A., Ryan L., Shackleton J., Trimlett R., Meis J.F. i wsp.: First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob. Resist. Infect. Control, DOI: 10.1186/s13756-016-0132-5 (2016)SchelenzS.HagenF.RhodesJ.L.AbdolrasouliA.ChowdharyA.HallA.RyanL.ShackletonJ.TrimlettR.MeisJ.F.i wsp.: First hospital outbreak of the globally emerging Candida auris in a European hospital.Antimicrob. Resist. Infect. Control, DOI: 10.1186/s13756-016-0132-5 (2016)Search in Google Scholar
87. Sexton D.J., Kordalewska M., Bentz M.L., Welsh R.M., Perlin D.S., Litvintseva A.P.: Direct detection of emergent fungal pathogen Candida auris in clinical skin swabs by SYBR Green-based quantitative PCR Assay. J. Clin. Microbiol. DOI: 10.1128/JCM.01337-18 (2018)SextonD.J.KordalewskaM.BentzM.L.WelshR.M.PerlinD.S.LitvintsevaA.P.:Direct detection of emergent fungal pathogen Candida auris in clinical skin swabs by SYBR Green-based quantitative PCR Assay.J. Clin. Microbiol. DOI: 10.1128/JCM.01337-18 (2018)Search in Google Scholar
88. Shaban S., Patel M., Ahmad A. Improved efficacy of antifungal drugs in combination with monoterpene phenols against Candida auris. Sci. Rep. DOI: 10.1038/s41598-020-58203-3 (2020)ShabanS.PatelM.AhmadA.Improved efficacy of antifungal drugs in combination with monoterpene phenols against Candida auris.Sci. Rep. DOI: 10.1038/s41598-020-58203-3 (2020)Search in Google Scholar
89. Sharma D., Paul R.A., Rudramurthy S.M., Kashyap N., Bhattacharya S., Soman R., Shankarnarayan S.A., Chavan D., Singh S., Das P. i wsp. : Impact of FKS1 genotype on echinocandin in vitro susceptibility in Candida auris and in vivo response in a murine model of infection. Antimicrob. Agents Chemother. DOI: 10.1128/AAC.01652-21 (2022)SharmaD.PaulR.A.RudramurthyS.M.KashyapN.BhattacharyaS.SomanR.ShankarnarayanS.A.ChavanD.SinghS.DasP.i wsp. : Impact of FKS1 genotype on echinocandin in vitro susceptibility in Candida auris and in vivo response in a murine model of infection.Antimicrob. Agents Chemother. DOI: 10.1128/AAC.01652-21 (2022)Search in Google Scholar
90. Sherry L., Ramage G., Kean R., Borman A., Johnson E.M., Richardson M.D., Rautemaa-Richardson R.: Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris. Emerg. Infect. Dis. 23, 328–331 (2017)SherryL.RamageG.KeanR.BormanA.JohnsonE.M.RichardsonM.D.Rautemaa-RichardsonR.:Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris.Emerg. Infect. Dis.23,328-331(2017)Search in Google Scholar
91. Short B., Brown J., Delaney C., Sherry L., Williams C., Ramage G., Kean R.: Candida auris exhibits resilient biofilm characteristics in vitro: implications for environmental persistence. J. Hosp. Infect. 103, 92–96 (2019)ShortB.BrownJ.DelaneyC.SherryL.WilliamsC.RamageG.KeanR.:Candida auris exhibits resilient biofilm characteristics in vitro: implications for environmental persistence.J. Hosp. Infect.103,92-96(2019)Search in Google Scholar
92. Srivastava V., Ahmad A.: Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol. PLoS One, DOI: 10.1371/journal.pone.0233102 (2020)SrivastavaV.AhmadA.:Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol.PLoS One, DOI: 10.1371/journal.pone.0233102 (2020)Search in Google Scholar
93. Villanueva-Lozano H., Trevino-Rangel R.D., Gonzalez G.M., Ramirez-Elizondo M.T., Lara-Medrano R., Aleman-Bocanegra M.C., Guajardo-Lara C.E., Gaona-Chavez N., Castilleja-Leal F., Torre-Amione G., Martinez-Resendez M.F.: Outbreak of Candida auris infection in a COVID-19 hospital in Mexico. Clin. Microbiol. Infect. 27, 813–816 (2021)Villanueva-LozanoH.Trevino-RangelR.D.GonzalezG.M.Ramirez-ElizondoM.T.Lara-MedranoR.Aleman-BocanegraM.C.Guajardo-LaraC.E.Gaona-ChavezN.Castilleja-LealF.Torre-AmioneG.Martinez-ResendezM.F.:Outbreak of Candida auris infection in a COVID-19 hospital in Mexico.Clin. Microbiol. Infect.27,813-816(2021)Search in Google Scholar
94. Wang X.J., Bing J., Zheng Q.S., Zhang F.F., Liu J.B., Yue H.Z., Tao L., Du H., Wang Y.N., Wang H., Huang G.H.: The first isolate of Candida auris in China: clinical and biological aspects. Emerg. Microbes Infect. DOI: 10.1038/s41426-018-0095-0. (2018)WangX.J.BingJ.ZhengQ.S.ZhangF.F.LiuJ.B.YueH.Z.TaoL.DuH.WangY.N.WangH.HuangG.H.:The first isolate of Candida auris in China: clinical and biological aspects.Emerg. Microbes Infect. DOI: 10.1038/s41426-018-0095-0. (2018)Search in Google Scholar
95. Wang Y.Y., Zou Y., Chen X.Q., Li H., Yin Z., Zhang B.C., Xu Y.B., Zhang Y.Q., Zhang R.L., Huang X.H.,i wsp.l: Innate immune responses against the fungal pathogen Candida auris. Nat. Commun. DOI: 10.1038/s41467-022-31201-x (2022).WangY.Y.ZouY.ChenX.Q.LiH.YinZ.ZhangB.C.XuY.B.ZhangY.Q.ZhangR.L.HuangX.H.,i wsp.l: Innate immune responses against the fungal pathogen Candida auris.Nat. Commun. DOI: 10.1038/s41467-022-31201-x (2022).Search in Google Scholar
96. White P.L., Dhillon R., Cordey A., Hughes H., Faggian F., Soni S., Pandey M., Whitaker H., May A., Morgan M., i wsp.: A national strategy to diagnose Coronavirus Disease 2019-Associated invasive fungal disease in the intensive care unit. Clin. Infect. Dis. 73, E1634-E1644 (2021)WhiteP.L.DhillonR.CordeyA.HughesH.FaggianF.SoniS.PandeyM.WhitakerH.MayA.MorganM.,i wsp.: A national strategy to diagnose Coronavirus Disease 2019-Associated invasive fungal disease in the intensive care unit.Clin. Infect. Dis.73,E1634-E1644(2021)Search in Google Scholar
97. Wiederhold N.P., Lockhart S.R., Najvar L.K., Berkow E.L., Jaramillo R., Olivo M., Garvey E.P., Yates C.M., Schotzinger R.J., Catano G., Patterson T.F. The Fungal Cyp51-specific inhibitor VT-1598 demonstrates in vitro and in vivo activity against Candida auris. Antimicrob. Agents Chemother. 63, e02233-18 (2019)WiederholdN.P.LockhartS.R.NajvarL.K.BerkowE.L.JaramilloR.OlivoM.GarveyE.P.YatesC.M.SchotzingerR.J.CatanoG.PattersonT.F.The Fungal Cyp51-specific inhibitor VT-1598 demonstrates in vitro and in vivo activity against Candida auris.Antimicrob. Agents Chemother.63,e02233-18(2019)Search in Google Scholar
98. Wiederhold N.P., Najvar L.K., Jaramillo R., Olivo M., Patterson H., Connell A., Fukuda Y., Mitsuyama J., Catano G., Patterson T.F. The Novel arylamidine T-2307 demonstrates in vitro and in vivo activity against Candida auris. Antimicrob. Agents Chemother. DOI: 10.1128/AAC.02198-19 (2020)WiederholdN.P.NajvarL.K.JaramilloR.OlivoM.PattersonH.ConnellA.FukudaY.MitsuyamaJ.CatanoG.PattersonT.F.The Novel arylamidine T-2307 demonstrates in vitro and in vivo activity against Candida auris.Antimicrob. Agents Chemother. DOI: 10.1128/AAC.02198-19 (2020)Search in Google Scholar
99. Wurster S., Albert N.D., Kontoyiannis D.P.: Candida auris bloodstream infection induces upregulation of the PD-1/PD-l1 immune checkpoint pathway in an immunocompetent mouse model. Msphere. DOI: 10.1128/msphere.00817-21 (2022)WursterS.AlbertN.D.KontoyiannisD.P.:Candida auris bloodstream infection induces upregulation of the PD-1/PD-l1 immune checkpoint pathway in an immunocompetent mouse model.Msphere. DOI: 10.1128/msphere.00817-21 (2022)Search in Google Scholar
100. Wurster S., Bandi A., Beyda N.D., Albert N.D., Raman N.M., Raad I.I., Kontoyiannis D.P.: Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris. J. Antimicrob. Chemother. 74, 1904-1910 (2019)WursterS.BandiA.BeydaN.D.AlbertN.D.RamanN.M.RaadI.I.KontoyiannisD.P.:Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.J. Antimicrob. Chemother.74,1904-1910(2019)Search in Google Scholar
101. Yue H.Z., Bing J., Zheng Q.S., Zhang Y.L., Hu T.R., Du H., Wang H., Huang G.H.: Filamentation in Candida auris, an emerging fungal pathogen of humans: passage through the mammalian body induces a heritable phenotypic switch. Emer. Microbes Infect. DOI: 10.1038/s41426-018-0187-x (2018)YueH.Z.BingJ.ZhengQ.S.ZhangY.L.HuT.R.DuH.WangH.HuangG.H.:Filamentation in Candida auris, an emerging fungal pathogen of humans: passage through the mammalian body induces a heritable phenotypic switch.Emer. Microbes Infect. DOI: 10.1038/s41426-018-0187-x (2018)Search in Google Scholar
102. Zamith-Miranda D., Heyman H.M., Couvillion S.P., Cordero R.J.B., Rodrigues M.L., Nimrichter L., Casadevall A., Amatuzzi R.F., Alves L.R., Nakayasu E.S., Nosanchuk J.D.: Comparative molecular and immunoregulatory analysis of extracellular vesicles from Candida albicans and Candida auris. Msystems. DOI: 10.1128/mSystems.00822-21 (2021)Zamith-MirandaD.HeymanH.M.CouvillionS.P.CorderoR.J.B.RodriguesM.L.NimrichterL.CasadevallA.AmatuzziR.F.AlvesL.R.NakayasuE.S.NosanchukJ.D.:Comparative molecular and immunoregulatory analysis of extracellular vesicles from Candida albicans and Candida auris.Msystems. DOI: 10.1128/mSystems.00822-21 (2021)Search in Google Scholar
